Pk-pd analysis of mechanism of toxicity of molecular target drugs: towards optimal treatment of cancer

• In: SYMPOSIUM: PK-PD FOR SUPPORTING CLINICAL DECISIONS AND POINT-OF-CARE DOSAGE on Monday, 14 April 2014, 10:30-12:00
• At: PSWC, Melbourne (Australia) (2014)
• Type: Presentation
• By: SUZUKI, Hiroshi (The University of Tokyo Hospital, Pharmacy, Tokyo, Japan)
• Abstract:

  Although molecular target drugs are used for the treatment of cancer, they are associated with selective adverse events. For the safe and efficient treatment of cancer, it is important to analyze the mechanism of toxicity of these drugs. In my presentation, the mechanism for the toxicity of sunitinib will be discussed. Although sunitinib is used..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login